IDStewardship

  • Home
  • Articles
  • LEARN ANTIBIOTICS
  • Study Guide
  • Resources
  • Q&A
  • #ASPchat
  • Contributors
  • About

Baloxavir marboxyl (Xofluza)

[Photo of baloxavir marboxyl (Xofluza)]

Photo source: Fierce Pharma

KEY POINTS

  • Baloxavir marboxyl (Xofluza) is a polymerase acidic endonuclease inhibitor that is active against the influenza virus
    •  Interferes with viral RNA polymerase complex that is necessary for viral gene transcription, which inhibits influenza virus replication
    • Has activity versus influenza A and influenza B
    • Viral resistance has been found due to amino acid substitutions in the polymerase acidic protein
      • As seasonal flu strains in circulation may vary, beware this may impact the utility of baloxavir marboxyl
  • FDA-approved on October 24th of 2018 for treatment of uncomplicated influenza in patients 12 years or greater who have been symptomatic for no more than 48 hours
    • Expanded in October 2019 to include patients who are:
      • otherwise healthy, or
      • at high risk of developing influenza-related complications
  • Available oral only
    • Body weight 40kg – 80kg: 40mg x1
    • Body weight > 80kg: 80mg x1
    • Avoid co-administration with cations (e.g., calcium, iron, magnesium, zinc)
    • No dose-adjustment listed for renal or hepatic impairment, but it has not been studied in severe renal or hepatic impairment
  • May impact effectiveness of live attenuated influenza vaccines
  • The most common side effects reported are: diarrhea, bronchitis, nasopharyngitis, headache, and nausea
  • The ISMP August 2019 Acute Care Medication Alert Newsletter listed concerning post-market adverse event data, including 382 reports of which all but 14 had a serious or fatal outcome. They noted 50 cases of anaphylactic shock, 7 of which were fatal and all were reported by a healthcare professional.
  • Anticipated to cost $150 per course (regardless of dose)
    • Approximately $100 more than a course of oseltamivir

RESOURCES

  • Xofluza Package Insert
  • Xofluza FDA Approval Press Release
  • Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents. NEJM 2018.
  • A Step Forward in the Treatment of Influenza. NEJM 2018.
  • Sixty seconds on . . . baloxavir. BMJ 2018. 
  • New flu drug offers convenience, fast activity, and a novel mechanism – but at a cost. NEJM Journal Watch: HIV and ID Observations 2018. 


 

Free Antibiotic Cheat Sheet

Study Guide

  • Pharmacotherapy Study Guide
  • Acyclovir
  • Albendazole
  • Amikacin
  • Aminoglycosides
  • Amphotericin B
  • Amoxicillin
  • Amoxicillin-Clavulanic Acid
  • Ampicillin
  • Ampicillin-sulbactam
  • Anidulafungin
  • Artesunate
  • Atovaquone
  • Azithromycin
  • Aztreonam
  • Bacitracin
  • Baloxavir marboxyl (Xofluza)
  • Bamlanivimab
  • Baricitinib
  • Bezlotoxumab
  • Casirivimab and Imdevimab
  • Caspofungin
  • Cefazolin
  • Cefepime
  • Cefiderocol
  • Ceftaroline
  • Ceftazidime
  • Ceftazidime-avibactam
  • Ceftolozane-Tazobactam
  • Ceftriaxone
  • Cefoxitin
  • Cephalexin
  • Ciprofloxacin
  • Clarithromycin
  • Clindamycin
  • Colistin (colistimethate)
  • Cycloserine
  • Dalbavancin
  • Daptomycin
  • Delafloxacin
  • Dicloxacillin
  • Doripenem
  • Doxycycline
  • Elbasvir/ grazoprevir
  • Eravacycline
  • Ertapenem
  • Erythromycin
  • Famciclovir
  • Fidaxomicin
  • Fluconazole
  • Flucytosine
  • Foscarnet
  • Fosfomycin
  • Ganciclovir
  • Gentamicin
  • Glecaprevir/ Pibrentasvir
  • Imipenem-cilastatin
  • Imipenem-cilastatin-relebactam
  • Isavuconazole
  • Itraconazole
  • Ivermectin
  • Ledipasvir/sofosbuvir
  • Lefamulin
  • Letermovir
  • Levofloxacin
  • Linezolid
  • Meropenem
  • Meropenem-vaborbactam
  • Metronidazole
  • Methenamine
  • Micafungin
  • Minocycline
  • Moxifloxacin
  • Nafcillin
  • Nitrofurantoin
  • Omadacycline
  • Oritavancin
  • Oseltamivir
  • Oxacillin
  • Penicillin
  • Penicillin Skin Test
  • Phenazopyridine
  • Piperacillin-tazobactam
  • Plazomicin
  • Polymyxin B
  • Posaconazole
  • Quinupristin-dalfopristin
  • Remdesivir
  • Ribavirin
  • Rifabutin
  • Rifampin
  • Secnidazole
  • Sofosbuvir/ velpatasvir/ voxilaprevir
  • Sulfadiazine
  • Sulfamethoxazole-Trimethoprim (Bactrim)
  • Tedizolid
  • Telavancin
  • Tigecycline
  • Tobramycin
  • Tocilizumab
  • Valacyclovir
  • Valganciclovir
  • Vancomycin
  • Voriconazole
  • Zidovudine
  • Zoster vaccine recombinant, adjuvanted (Shingrix)

Recent

  • How Ibrexafungerp Got Its Name
  • Five Challenges With Creating And Managing Institutional Guidelines For Infectious Diseases
  • Three Resources Pharmacists Can Use To Improve Their Antimicrobial Stewardship Research Skills
  • A Comparison Of Bamlanivimab Versus Bamlanivimab-Etesevimab
  • Top 10 Most Viewed IDstewardship Articles During the COVID-19 Pandemic

Search

Copyright 2016-2020 By Charlie Rose, LLC © · IDStewardship.com · Copyright · Privacy Policy · Terms · Contact